Anti-tumor activity of N-trimethyl chitosan-encapsulated camptothecin in a mouse melanoma model. 2010

Xian-Ping Liu, and Sheng-Tao Zhou, and Xing-Yi Li, and Xian-Cheng Chen, and Xia Zhao, and Zhi-Yong Qian, and Li-Na Zhou, and Zhi-Yong Li, and Yu-Mei Wang, and Qian Zhong, and Tao Yi, and Zheng-Yu Li, and Xiang He, and Yu-Quan Wei
Department of Gynecology and Obstetrics, West China Second Hospital, Sichuan University, Chengdu, China.

BACKGROUND Camptothecin (CPT) has recently attracted increasing attention as a promising anticancer agent for a variety of tumors. But the clinical application is largely hampered by its extreme water insolubility and unpredictable side effect. It is essential to establish an efficient and safe protocol for the administration of CPT versus melanoma. METHODS Camptothecin was encapsulated with N-trimethyl chitosan (CPT-TMC) through microprecipitation and sonication. Its inhibition effect on B16-F10 cell proliferation and induction of apoptosis was evaluated by MTT assay and flow cytometric analysis in vitro. The anti-tumor activity of CPT-TMC was evaluated in C57BL/6 mice bearing B16-F10 melanoma. Tumor volume, tumor weight and survival time were recorded. Assessment of apoptotic cells within tumor tissue was performed by TUNEL assay. Antiangiogenesis and antiproliferation effects of CPT-TMC in vivo were conducted via CD31 and PCNA immunohistochemistry, respectively. RESULTS CPT-TMC efficiently inhibited B16-F10 cells proliferation and increased apoptosis in vitro. Experiment group showed significant inhibition compared with free CPT-treated group (81.3% vs. 56.9%) in the growth of B16-F10 melanoma xenografts and prolonged the survival time of the treated mice (P < 0.05). Decreased cell proliferation, increased tumor apoptosis as well as a reduction in angiogenesis were observed. CONCLUSIONS Our data suggest that N-trimethyl chitosan-encapsulated camptothecin is superior to free CPT by overcoming its insolubility and finally raises the potential of its application in melanoma therapy.

UI MeSH Term Description Entries
D007124 Immunoenzyme Techniques Immunologic techniques based on the use of: (1) enzyme-antibody conjugates; (2) enzyme-antigen conjugates; (3) antienzyme antibody followed by its homologous enzyme; or (4) enzyme-antienzyme complexes. These are used histologically for visualizing or labeling tissue specimens. Antibody Enzyme Technique, Unlabeled,Enzyme Immunoassay,Enzyme-Labeled Antibody Technique,Immunoassay, Enzyme,Immunoperoxidase Techniques,Peroxidase-Antiperoxidase Complex Technique,Peroxidase-Labeled Antibody Technique,Antibody Enzyme Technic, Unlabeled,Enzyme-Labeled Antibody Technic,Immunoenzyme Technics,Immunoperoxidase Technics,Peroxidase-Antiperoxidase Complex Technic,Peroxidase-Labeled Antibody Technic,Antibody Technic, Enzyme-Labeled,Antibody Technic, Peroxidase-Labeled,Antibody Technics, Enzyme-Labeled,Antibody Technics, Peroxidase-Labeled,Antibody Technique, Enzyme-Labeled,Antibody Technique, Peroxidase-Labeled,Antibody Techniques, Enzyme-Labeled,Antibody Techniques, Peroxidase-Labeled,Enzyme Immunoassays,Enzyme Labeled Antibody Technic,Enzyme Labeled Antibody Technique,Enzyme-Labeled Antibody Technics,Enzyme-Labeled Antibody Techniques,Immunoassays, Enzyme,Immunoenzyme Technic,Immunoenzyme Technique,Immunoperoxidase Technic,Immunoperoxidase Technique,Peroxidase Antiperoxidase Complex Technic,Peroxidase Antiperoxidase Complex Technique,Peroxidase Labeled Antibody Technic,Peroxidase Labeled Antibody Technique,Peroxidase-Antiperoxidase Complex Technics,Peroxidase-Antiperoxidase Complex Techniques,Peroxidase-Labeled Antibody Technics,Peroxidase-Labeled Antibody Techniques,Technic, Enzyme-Labeled Antibody,Technic, Immunoenzyme,Technic, Immunoperoxidase,Technic, Peroxidase-Antiperoxidase Complex,Technic, Peroxidase-Labeled Antibody,Technics, Enzyme-Labeled Antibody,Technics, Immunoenzyme,Technics, Immunoperoxidase,Technics, Peroxidase-Antiperoxidase Complex,Technics, Peroxidase-Labeled Antibody,Technique, Enzyme-Labeled Antibody,Technique, Immunoenzyme,Technique, Immunoperoxidase,Technique, Peroxidase-Antiperoxidase Complex,Technique, Peroxidase-Labeled Antibody,Techniques, Enzyme-Labeled Antibody,Techniques, Immunoenzyme,Techniques, Immunoperoxidase,Techniques, Peroxidase-Antiperoxidase Complex,Techniques, Peroxidase-Labeled Antibody
D008546 Melanoma, Experimental Experimentally induced tumor that produces MELANIN in animals to provide a model for studying human MELANOMA. B16 Melanoma,Melanoma, B16,Melanoma, Cloudman S91,Melanoma, Harding-Passey,Experimental Melanoma,Experimental Melanomas,Harding Passey Melanoma,Melanomas, Experimental,B16 Melanomas,Cloudman S91 Melanoma,Harding-Passey Melanoma,Melanoma, Harding Passey,Melanomas, B16,S91 Melanoma, Cloudman
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D002166 Camptothecin An alkaloid isolated from the stem wood of the Chinese tree, Camptotheca acuminata. This compound selectively inhibits the nuclear enzyme DNA TOPOISOMERASES, TYPE I. Several semisynthetic analogs of camptothecin have demonstrated antitumor activity. Camptothecine
D004337 Drug Carriers Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers. Drug Carrier
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000972 Antineoplastic Agents, Phytogenic Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. Antineoplastics, Botanical,Antineoplastics, Phytogenic,Agents, Phytogenic Antineoplastic,Botanical Antineoplastics,Phytogenic Antineoplastic Agents,Phytogenic Antineoplastics
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities

Related Publications

Xian-Ping Liu, and Sheng-Tao Zhou, and Xing-Yi Li, and Xian-Cheng Chen, and Xia Zhao, and Zhi-Yong Qian, and Li-Na Zhou, and Zhi-Yong Li, and Yu-Mei Wang, and Qian Zhong, and Tao Yi, and Zheng-Yu Li, and Xiang He, and Yu-Quan Wei
April 2012, Oncology reports,
Xian-Ping Liu, and Sheng-Tao Zhou, and Xing-Yi Li, and Xian-Cheng Chen, and Xia Zhao, and Zhi-Yong Qian, and Li-Na Zhou, and Zhi-Yong Li, and Yu-Mei Wang, and Qian Zhong, and Tao Yi, and Zheng-Yu Li, and Xiang He, and Yu-Quan Wei
October 2010, Oncology reports,
Xian-Ping Liu, and Sheng-Tao Zhou, and Xing-Yi Li, and Xian-Cheng Chen, and Xia Zhao, and Zhi-Yong Qian, and Li-Na Zhou, and Zhi-Yong Li, and Yu-Mei Wang, and Qian Zhong, and Tao Yi, and Zheng-Yu Li, and Xiang He, and Yu-Quan Wei
September 2015, Journal of nanoscience and nanotechnology,
Xian-Ping Liu, and Sheng-Tao Zhou, and Xing-Yi Li, and Xian-Cheng Chen, and Xia Zhao, and Zhi-Yong Qian, and Li-Na Zhou, and Zhi-Yong Li, and Yu-Mei Wang, and Qian Zhong, and Tao Yi, and Zheng-Yu Li, and Xiang He, and Yu-Quan Wei
May 2018, Vaccine,
Xian-Ping Liu, and Sheng-Tao Zhou, and Xing-Yi Li, and Xian-Cheng Chen, and Xia Zhao, and Zhi-Yong Qian, and Li-Na Zhou, and Zhi-Yong Li, and Yu-Mei Wang, and Qian Zhong, and Tao Yi, and Zheng-Yu Li, and Xiang He, and Yu-Quan Wei
December 2022, Archives of Razi Institute,
Xian-Ping Liu, and Sheng-Tao Zhou, and Xing-Yi Li, and Xian-Cheng Chen, and Xia Zhao, and Zhi-Yong Qian, and Li-Na Zhou, and Zhi-Yong Li, and Yu-Mei Wang, and Qian Zhong, and Tao Yi, and Zheng-Yu Li, and Xiang He, and Yu-Quan Wei
November 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
Xian-Ping Liu, and Sheng-Tao Zhou, and Xing-Yi Li, and Xian-Cheng Chen, and Xia Zhao, and Zhi-Yong Qian, and Li-Na Zhou, and Zhi-Yong Li, and Yu-Mei Wang, and Qian Zhong, and Tao Yi, and Zheng-Yu Li, and Xiang He, and Yu-Quan Wei
November 2022, International journal of biological macromolecules,
Xian-Ping Liu, and Sheng-Tao Zhou, and Xing-Yi Li, and Xian-Cheng Chen, and Xia Zhao, and Zhi-Yong Qian, and Li-Na Zhou, and Zhi-Yong Li, and Yu-Mei Wang, and Qian Zhong, and Tao Yi, and Zheng-Yu Li, and Xiang He, and Yu-Quan Wei
November 2006, Experimental dermatology,
Xian-Ping Liu, and Sheng-Tao Zhou, and Xing-Yi Li, and Xian-Cheng Chen, and Xia Zhao, and Zhi-Yong Qian, and Li-Na Zhou, and Zhi-Yong Li, and Yu-Mei Wang, and Qian Zhong, and Tao Yi, and Zheng-Yu Li, and Xiang He, and Yu-Quan Wei
October 2018, International journal of biological macromolecules,
Xian-Ping Liu, and Sheng-Tao Zhou, and Xing-Yi Li, and Xian-Cheng Chen, and Xia Zhao, and Zhi-Yong Qian, and Li-Na Zhou, and Zhi-Yong Li, and Yu-Mei Wang, and Qian Zhong, and Tao Yi, and Zheng-Yu Li, and Xiang He, and Yu-Quan Wei
September 2012, Carbohydrate polymers,
Copied contents to your clipboard!